Primary refractory and relapsed diffuse large B-cell lymphoma: current treatment options and ongoing developments, an activity

Reading time: 13 minutes (special: includes a pre- and post-article quiz activity!) Néstor Zumaya Image from: Bock AM, Narendranath Epperla. Therapeutic landscape of primary refractory and relapsed diffuse large B-cell lymphoma: Recent advances and emerging therapies. Journal of Hematology & Oncology. 2025 Jul 1;18(1). Activity: Choose the right answer based on your current knowledge. You’ll... Continue Reading →

December 10, 2025 0

A new multi-pronged approach to cancer vaccination

Reading time: 4 minutes Taylor B. Poston, Ph.D., M.P.H. Most tumors do not respond to T-cell based immunotherapies, but the explanation for this phenomenon has been unclear. Researchers have speculated that there could be insufficient priming of anti-tumor T cells, or if T cells are primed, they are unable to recognize and eradicate the tumor.... Continue Reading →

August 28, 2019 0

Up ↑

Tag: lymphoma

Primary refractory and relapsed diffuse large B-cell lymphoma: current treatment options and ongoing developments, an activity

A new multi-pronged approach to cancer vaccination

Categories

Follow OncoBites via Email

Tags

Follow OncoBites on Twitter